期刊文献+

类风湿性关节炎患者合并潜伏性结核感染危险因素及Treg、Th17的预测价值 被引量:1

Risk factors for latent tuberculosis infection in patients with rheumatoid arthritis and predictive values of Treg and Th17
原文传递
导出
摘要 目的分析类风湿性关节炎患者合并潜伏性结核感染的危险因素及调节性T淋巴细胞(Treg)和辅助性T淋巴细胞17(Th17)的预测价值.方法回顾性收集2021年1月-2022年8月石河子大学第一附属医院收治的119例类风湿性关节炎患者临床资料,根据患者是否合并潜伏性结核感染分为感染组32例和未感染组87例,单因素及多因素Logistic回归分析类风湿性关节炎患者合并潜伏性结核感染的危险因素,采用受试者工作特征(ROC)曲线分析Treg、Th17及Th17/Treg对类风湿性关节炎患者合并潜伏性结核感染的预测价值.结果119例类风湿性关节炎患者合并潜伏性结核感染32例,感染率为26.89%;侵入性操作、1年内激素使用日均剂量较大、骨密度T值较低均为类风湿性关节炎患者合并潜伏性结核感染的独立危险因素(P<0.05);感染组外周血Treg、Th17及Th17/Treg水平均高于未感染组(P<0.05);ROC曲线结果显示,Treg、Th17及Th17/Treg联合预测类风湿性关节炎患者合并潜伏性结核感染的临床价值较高,曲线下面积(AUC)为0.903、特异度和敏感度分别为80.46%和90.62%.结论类风湿性关节炎患者潜伏性结核感染发生率较高,其危险因素包括侵入性操作、1年内激素使用日均剂量较多、骨密度T值,Treg、Th17及Th17/Treg联合对类风湿性关节炎患者潜伏性结核感染具有较好的预测价值. OBJECTIVE To analyze the risk factors for latent tuberculosis infection in the patients with rheumatoid arthritis and observe the predictive values of regulatory T lymphocyte(Treg)and helper T lymphocyte 17(Th17).METHODS The clinical data were retrospectively collected from 119 rheumatoid arthritis patients who were treated in the First Affiliated Hospital of Shihezi University from Jan 2021 to Aug 2022.The enrolled patients were divided into the infection group with 32 cases and the no infection group according to the status of complication with latent tuberculosis infection.Univariate analysis and multivariate logistic regression analysis were performed for the risk factors for the latent tuberculosis infection in the patients with rheumatoid arthritis.The values of Treg,Th17 and Th17/Treg in prediction of latent tuberculosis infection were analyzed by means of receiver operating characteristic(ROC)curves.RESULTS Among the 119 patients with rheumatoid arthritis,32 were complicated with latent tuberculosis infection,with the infection rate 26.89%.Invasive procedure,daily use of high dose of hormone within 1 year and low T value of bone mineral density were the independent risk factors for the latent tuberculosis infection in the patients with rheumatoid arthritis(P<0.05).The levels of peripheral blood Treg,Th17 and Th17/Treg of the infection group were higher than those of the no infection group(P<0.05).ROC curve analysis showed that the joint detection of Treg,Th17 and Th17/Treg had high clinical value in prediction of latent tuberculosis infection in the patients with rheumatoid arthritis,the area under curve(AUC)was O.903,with the sensitivity 80.46%,the specificity 90.62%,the sensitivity 90.62%.CONCLUSION The incidence of latent tuberculosis infection is high among the patients with rheumatoid arthritis.The risk factors include the invasive procedure,daily use of high dose of hormone within 1 year and T value of bone mineral density.The joint detection of Treg,Th17 and Th17/Treg has high value in prediction o
作者 余丽君 潘歆 詹爱琴 陈晨 魏亚州 YU Li-jun;PAN Xin;ZHAN Ai-qin;CHEN Chen;WEI Ya-zhou(The First Affiliated Hospital of Shihezi University,Shihezi,Xinjiang 832000,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2023年第17期2600-2604,共5页 Chinese Journal of Nosocomiology
基金 新疆维吾尔自治区科研基金资助项目(2021LJ03411)。
关键词 类风湿性关节炎 潜伏性结核感染 现状 调节性T淋巴细胞 危险因素 Rheumatoid arthritis Latent tuberculosis infection Current status Regulatory T lymphocyte Risk factor
  • 相关文献

参考文献11

二级参考文献56

  • 1St Clair EW, Pisetsky DS, Haynes BF.类风湿关节炎.王吉波,吕振华,译.北京:人民卫生出版,2008:13-16. 被引量:1
  • 2Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum, 2010, 62(9): 2569-2581. 被引量:1
  • 3Sandan M, Sandan P, Perneger T, et al. Celecoxib versus ibuprofen in the prevention of heterotopic ossification following total hip replacement: a prospective randomised trial. J Bone Joint Surg Br, 2007, 89(2): 155-159. 被引量:1
  • 4van der Heijde D, Klareskog L, Rodriguez-Valverde V, et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiograhpic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum, 2006, 54(4): 1063-1074. 被引量:1
  • 5van der Heijde D, Klareskog L, Landewe R, et al. Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis. Arthritis Rheum, 2007, 56(12): 3928-3939. 被引量:1
  • 6Horiuchi T, Mitoma H, Harashima S, et al. Transmembrane TNF- alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford), 2010, 49(7): 1215-1228. 被引量:1
  • 7Maksymowyeh WP. Update on the treatment of ankylosing spondylitis. Ther Clin Risk Manag, 2007, 3(6): 1125-1133. 被引量:1
  • 8Braun J, van den Berg R, Baraliakos X, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis, 2011, 70(6): 896-904. 被引量:1
  • 9Dougaclos M, Braun J, Szanto S, et al. Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo- controlled study (SPINE). Ann Rheum Dis, 2011, 70(5): 799-804. 被引量:1
  • 10Braun J, van der Horst-Bruinsma IE, Huang F, et al. Clinical ef- ficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: a randomized, double-blind trial. Arthritis Rheum, 2011, 63(6): 1543-1551. 被引量:1

共引文献75

同被引文献23

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部